These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 8942881)

  • 1. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
    Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
    Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
    O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
    Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
    Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
    Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
    Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.
    Khokhar S; Sindhu N; Mirdha BR
    Infection; 2000; 28(3):149-52. PubMed ID: 10879638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis.
    Baker RS; Flowers CW; Casey R; Fong DS; Wilson MR
    Arch Ophthalmol; 1996 May; 114(5):632-3. PubMed ID: 8619784
    [No Abstract]   [Full Text] [Related]  

  • 9. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
    Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.
    Gangopadhyay N; Daniell M; Weih L; Taylor HR
    Br J Ophthalmol; 2000 Apr; 84(4):378-84. PubMed ID: 10729294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
    Sharma N; Arora T; Jain V; Agarwal T; Jain R; Jain V; Yadav CP; Titiyal J; Satpathy G
    Cornea; 2016 Jan; 35(1):56-61. PubMed ID: 26509763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxifloxacin for bacterial keratitis.
    Rosenberg J; Eisen L; Kim J
    Ophthalmology; 2008 Jun; 115(6):1103; author reply 1103. PubMed ID: 18519075
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis.
    Prajna NV; George C; Selvaraj S; Lu KL; McDonnell PJ; Srinivasan M
    Cornea; 2001 Mar; 20(2):175-8. PubMed ID: 11248824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials.
    McDonald EM; Ram FS; Patel DV; McGhee CN
    Br J Ophthalmol; 2014 Nov; 98(11):1470-7. PubMed ID: 24729078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Lauffenburger MD; Cohen KL
    Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers.
    Booranapong W; Kosrirukvongs P; Prabhasawat P; Srivannaboon S; Suttiprakarn P
    J Med Assoc Thai; 2004 Mar; 87(3):246-54. PubMed ID: 15117040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis.
    Erjongmanee S; Kasetsuwan N; Phusitphoykai N; Puangsricharern V; Pariyakanok L
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S83-90. PubMed ID: 16083168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
    Bashir H; Dave A; Mathur U
    Cornea; 2016 Aug; 35(8):e22-3. PubMed ID: 27227400
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluoroquinolones in the treatment of bacterial keratitis.
    Bower KS; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.